feed,title,long_url,short_url
ğŸ”MarketWatch,Evelo Biosciences to review options after Phase 2 trial of psoriasis treatment fails to meet main goal,http://www.marketwatch.com/news/story/evelo-biosciences-review-options-after/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D7280%2D716A7A1A6937%7D&siteid=rss,https://da.gd/Gdhv4X
ğŸ”MarketWatch,Gilead to pay Assembly Bio an initial $100 million as part of 12-year partnership to develop antiviral drugs,http://www.marketwatch.com/news/story/gilead-pay-assembly-bio-initial/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D7280%2D6D8E1FC179F1%7D&siteid=rss,https://da.gd/PwZNwI
ğŸ”MarketWatch,Choice Hotels launches hostile bid to acquire Wyndham Hotels for $90 per share,http://www.marketwatch.com/news/story/choice-hotels-launches-hostile-bid/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D7280%2D68AE9BD84F8C%7D&siteid=rss,https://da.gd/qqtef
